Currently out of the existing stock ratings of Michael Polark, 1870 are a BUY (75.46%), 595 are a HOLD (24.01%), 13 are a SELL (0.52%).

Michael Polark

Work Performance Price Targets & Ratings Chart

Analyst Michael Polark works at WOLFE with a stock forecast success ratio of 59.17% fulfilled within 88.19 days on average. Previously, Michael Polark worked at BAIRD.

Michael Polark’s has documented 107 price targets and ratings displayed on 17 stocks. The coverage is on Healthcare, Technology sectors.

Most recent stock forecast was given on MASI, Masimo at 15-Sep-2022.

Wall Street Analyst Michael Polark

Analyst best performing recommendations are on NVRO (NEVRO CORP).
The best stock recommendation documented was for NVRO (NEVRO CORP) at 4/6/2022. The price target of $64 was fulfilled within 23 days with a profit of $11.91 (15.69%) receiving and performance score of 6.82.

Average potential price target upside

AXNX Axonics Modulation Technologies HRC Hill-Rom Holdings ISRG Intuitive Surgical NVRO Nevro Corp RMD ResMed SHC Sotera Health Co STE STERIS plc INSP Inspire Medical Systems LIVN LivaNova PLC NPCE Neuropace IRT Independence Realty Trust VCRA Vocera Communications ABMD ABIOMED MASI Masimo SILK Silk Road Medical NYXH Nyxoah SWAV Shockwave Medical

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

63

1 months 5 days ago

9/13 (69.23%)

$11.79 (23.02%)

133

Buy

71

$3.12 (4.60%)

73

1 months 6 days ago

1/7 (14.29%)

$2.66 (3.89%)

173

Buy

71

$3.12 (4.60%)

75

1 months 10 days ago

20/24 (83.33%)

$2.28 (3.32%)

162

Buy

69

$1.12 (1.65%)

76

3 months 22 days ago

2/5 (40%)

$17.79 (34.74%)

50

Buy

71

$3.12 (4.60%)

70

6 months 25 days ago

0/2 (0%)

$10.15 (16.68%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Michael Polark?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?